TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors

Oliveira ÉAD., Chauhan J., Silva JRD., Carvalho LADC., Dias D., Carvalho DGD., Watanabe LRM., Rebecca VW., Mills G., Lu Y., da Silva ASF., Consolaro MEL., Herlyn M., Possik PA., Goding CR., Maria-Engler SS.

DOI

10.1016/j.phrs.2021.105911

Type

Journal article

Journal

Pharmacological Research

Publisher

Elsevier BV

Publication Date

11/2021

Volume

173

Pages

105911 - 105911

Permalink Original publication